Can-Fite BioPharma (CANF) Announces Receipt of CF101-Related Lawsuit Requesting Class Action Status
Tweet Send to a Friend
Can-Fite BioPharma (NYSE: CANF) disclosed the following on Tuesday:On June 29, 2015, Can-Fite BioPharma Ltd. (the “Company”) received a lawsuit ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
